ClinicalTrials.gg
RecruitingNCT05960461Updated Sep 10, 2026

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

An interventional study of FMF (Families Moving Forward) Connect Pro and ECHO (Extension of Community Healthcare Outcomes) implementation. in Fetal Alcohol Spectrum Disorders, sponsored by University of Rochester. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by University of Rochester · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States — 10 open to participants now, 11 under way, none of them phase 3. Fetal Alcohol Spectrum Disorders · United States.

Planned enrollment
6th of 34
250 · median 85
Started
2024
with 1 other
No phase
22 of 37
9 open now
Primary completion
2027-04
later than 5 of 10 live
Registered
28th of 37
by date
Lead sponsor
9 of 37
University of Rochester

Among the 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States, this one is the 6th largest by planned enrollment of the 34 interventional ones that give a count, is one of 2 that started in 2024, is one of 22 with no phase, reaches primary completion later than 5 of the 10 other live ones, and was the 28th registered.

Fetal Alcohol Spectrum Disorders

65 studies on the registry are indexed under Fetal Alcohol Spectrum Disorders; 13 are open to participants now.

Browse Fetal Alcohol Spectrum Disorders studies →

Open to participants now

10 of the 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 12 Fetal Alcohol Spectrum Disorders studies recruiting now, 4 (33%) set no upper age limit and 8 (67%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Fetal Alcohol Spectrum Disorders with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app.

Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website.

The main questions this study aims to answer are:

  • What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)?
  • Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change?

All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.

03

Conditions studied

  • Fetal Alcohol Spectrum Disorders
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Licensed mental health provider or supervised trainee
  • Employed by a community mental agency or in private practice
  • provides mental health services to children ages 3 to 12 or their families
  • provides services in the United States
  • Fluency in English
  • Access to the internet

Exclusion criteria

Exclusion Criteria:

  • Provides services outside of the United States
  • Does not provide mental health services to children ages 3 to 12
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    FMF (Families Moving Forward) Connect Pro with ECHO implementation

    Mental health providers are trained in FMF Connect Pro with ECHO (Extension of Community Healthcare Outcomes) tele-mentoring. FMF Connect Pro teaches mental health providers how to do routine screening of prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support caregivers in using the FMF Connect app. The FMF Connect Pro Dashboard organizes intervention content for providers and includes tools for client progress monitoring. In this arm, providers receive training in FMF Connect Pro through 13 bi-weekly ECHO tele-mentoring sessions. Each ECHO session involves brief didactic presentations by Hub Team members on FASD-informed care principles and FMF Connect content and case-based discussions and recommendations by Spoke Sites.

    Behavioral: FMF (Families Moving Forward) Connect Pro · Behavioral: ECHO (Extension of Community Healthcare Outcomes) implementation.

  • Experimental
    FMF (Families Moving Forward) Connect Pro with Self-directed materials

    Mental health providers are trained in FMF Connect Pro with self-directed materials. FMF Connect Pro teaches mental health providers how to do routine screening of prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support caregivers in using the FMF Connect app. The FMF Connect Pro Dashboard organizes intervention content for providers and includes tools for client progress monitoring. In this arm, mental health providers will access similar didactic content as ECHO participants, but in an asynchronous format on the FMF Connect Pro Dashboard. This will include pre-recorded videos, activities, and additional resources for further learning.

    Behavioral: FMF (Families Moving Forward) Connect Pro · Behavioral: Self-Directed Learning implementation.

  • No intervention
    Waitlist Comparison Group

    The waitlist comparison group will receive FMF Connect Pro via Self-directed materials after completing assessments at the 6-month timepoint.

Interventions

  • BehavioralFMF (Families Moving Forward) Connect Pro

    FMF Connect Pro is a program supported by mental health providers to increase access to care for children (ages 3 to 12) with fetal alcohol spectrum disorders (FASD) and their families. FMF Connect Pro teaches and supports providers in 3 main activities: 1. Routine screening of prenatal alcohol exposure (PAE) 2. Apply DSM-5 diagnostic criteria for "Neurodevelopmental Disorder Associated with Prenatal Alcohol Exposure (ND-PAE)" 3. Support caregivers using the FMF Connect app FMF Connect Pro involves a Provider Dashboard with several main sections: * Learning - includes content and additional resources to support providers in learning how to screen PAE, diagnose ND-PAE, and support families using the FMF Connect app. * Tools and Resources - includes: screening, diagnostic, and documentation templates; app tip sheets; workbooks; supporting articles, websites, and other resources * Clients - providers can track clients' progress using the FMF Connect app

  • BehavioralECHO (Extension of Community Healthcare Outcomes) implementation.

    Mental health providers participate in a 13-session tele-mentoring training program using the ECHO (Extension of Community Healthcare Outcomes) approach. Each session involves a brief didactic presentation and case-based learning using de-identified cases shared by participants. The curriculum teaches providers how to do FMF Connect Pro.

  • BehavioralSelf-Directed Learning implementation.

    Mental health providers complete 13 learning modules asynchronously on the FMF Connect Pro Dashboard. These modules include pre-recorded didactic content, brief exercises to assess learning, and additional resources. The curriculum teaches providers how to do FMF Connect Pro.

06

What researchers measure

Primary outcomes

  1. Reach: proportion of agencies who accept introductory webinar presentation

    Research staff will document the number of mental health agencies who agree to participate in the introductory webinar presentation out of the total number approached.

    Time frame: 3 months prior to baseline

  2. Reach: proportion of mental health providers who enroll in the study

    Research staff will document the number of mental health providers who enroll in the study out of the total number of providers who attend the introductory webinar at recruitment.

    Time frame: 3 months prior to baseline

  3. Reach: proportion of mental health providers who complete data collection

    Research staff will document the number of mental health providers who complete follow-up data collection out of the total number of providers who enrolled in the study.

    Time frame: baseline to 6 months

  4. Effectiveness: Percentage of clients screened for prenatal alcohol exposure

    Mental health providers will be asked as part of the Practice Change survey at each time point the percentage of clients they screen for prenatal alcohol exposure.

    Time frame: baseline to 1 year

  5. Effectiveness: Number of clients diagnosed with a fetal alcohol spectrum disorder

    Mental health providers will be asked at each time point the number of clients they have diagnosed with a fetal alcohol spectrum disorder (using the DSM-5 Neurodevelopmental Disorder Associated with Prenatal Alcohol Exposure criteria).

    Time frame: baseline to 1 year

  6. Effectiveness: Number of clients enrolled in FMF Connect Pro Dashboard

    FMF Connect Pro Dashboard analytics will be examined to assess the number of clients providers have enrolled in FMF Connect.

    Time frame: baseline to 1 year

  7. Adoption: Number of ECHO Sessions Completed

    Participant attendance at each ECHO session will be measured for FMF Connect Pro with ECHO implementation group. There are 13 total sessions.

    Time frame: 6 months

  8. Adoption: Number of Self-Directed Sessions Completed

    Participant completion of each self-directed learning module will be measured for the FMF Connect Pro with Self-Directed implementation group. There are 13 total modules.

    Time frame: 6 months

  9. Adoption: Change in Provider FASD-Informed Care Knowledge

    Participant knowledge will be assessed using the Knowledge of FASD-Informed Care survey. This survey assesses the content and principles of FASD-informed care. The survey has 30 questions, with each question worth 1 point. Scores range from 0 to 30, with higher scores reflecting greater knowledge.

    Time frame: baseline to 6 months

  10. Adoption: Change in FASD-Informed Care Self-Efficacy

    Participant self-efficacy will be assessed using the FASD-Informed Care Self-Efficacy scale. This scale assesses provider self-efficacy in specific FASD- informed care skills in mental health settings. The measure includes 12 items. Items are rated on a 6-point Likert scale from 1 "no confidence" to 6 "highly confident/expert." Scores range from 12 to 72, with higher scores reflecting greater confidence or self-efficacy.

    Time frame: baseline to 6 months

  11. Implementation: Change in FASD-informed practice

    Participant practice change will be assessed using the FASD- Informed Care Practice Change scale. This measure is aligned with specific FASD-informed care behaviors taught in ECHO and self-directed versions of FMF Connect Pro. This measure includes 15 items rated on a 5-point scale, with scores ranging from 15 to 75. Higher scores reflect clinical practice more consistent with FASD-informed care.

    Time frame: baseline to 6 months

  12. Maintenance: Change in FASD-informed practice

    Participant practice change will be assessed using the FASD- Informed Care Practice Change scale. This measure is aligned with specific FASD-informed care behaviors taught in ECHO and self-directed versions of FMF Connect Pro. This measure includes 15 items rated on a 5-point scale, with scores ranging from 15 to 75. Higher scores reflect clinical practice more consistent with FASD-informed care.

    Time frame: 6 months to 1 year

  13. Implementation and Maintenance: FMF Connect Pro Dashboard usage

    FMF Connect Pro Dashboard analytics will be extracted to measure the number of times providers accessed the website.

    Time frame: baseline to 1 year

Secondary outcomes

  1. Contextual determinants on outcomes: Mean score on the Theoretical Domains Framework (TDF) survey

    Providers will complete an adapted version of the Theoretical Domains Framework (TDF) survey to assess possible barriers and facilitators impacting implementation of the intervention. The survey includes 27 items. Responses are scored from 1(strongly disagree) to 7 (strongly agree). Scores range from 27 to 189, with higher scores reflecting greater agreement.

    Time frame: baseline to 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified study data will be transferred to the National Institute of Alcohol Abuse and Alcoholism (NIAAA) Data Archive (NDA), as required.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be transferred twice a year as required by NIAAA-DA. Per current NIAAA NDA policy (on website), the research community will have access to data two years after the award ends. NDA will make decisions about how long to preserve the data, but that data archive has not deleted any deposited data up to now.

Access criteria: Data will be findable for the research community through the NDA Collection for this project when funded. For all publications, an NDA study will be created. Each of those studies is assigned a digital object identifier (DOI). This data DOI will be referenced in the publication to allow the research community easy access to the exact data used in the publication.

Data sharing details ↗ · nda.nih.gov

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Apr 2027, 37 months after the start.

Of 28 interventional studies with no phase under Fetal Alcohol Spectrum Disorders, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 37 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2023
First posted
Jul 25, 2023
StartActual
Mar 22, 2024
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05960461
Responsible party
Christie Petrenko (Professor, University of Rochester) — Principal investigator
First posted
Jul 25, 2023
Start date
Mar 22, 2024
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Sep 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion